Image

Exercising in Hot Conditions: How Does it Effect Blood Glucose in People With T1D

Exercising in Hot Conditions: How Does it Effect Blood Glucose in People With T1D

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

A randomised, crossover, counterbalanced repeated measures study will be conducted to examine the effect of acute heat exposure on rate of change in blood glucose concentration during 40 minutes of moderate-intensity exercise and for 30 minutes after exercise. Participants will complete two experimental conditions during two separate laboratory visits, with the order of conditions randomised. One condition will be a temperate condition of 20°C with 50% relative humidity (Temperate), the other will be 40°C with 50% relative humidity (Heat). Visits will be identical, including time of day, except for the condition. Visits will be separated by 24h. Testing will take place in the laboratories of the Research Institute for Sport and Exercise Sciences at Liverpool John Moores University.

Eligibility

Inclusion Criteria:

  • T1D diagnosis more than 1 years ago (to ensure participants are out of the honeymoon period)
  • Using insulin therapy with multiple daily injections (MDI), insulin pump (pump), or hybrid closed-loop (HCL)
    • If using a HCL system have experience of using a pre-programmed basal rate in manual mode during exercise
  • Aged 18-65 years
  • Regularly engaged in endurance exercise (training at least twice per week for ≥30 minutes per session)

Exclusion Criteria:

  • Pregnancy
  • \<6 months postpartum or stopped breastfeeding \<1 month before recruitment
  • Existing cerebrovascular or cardiovascular disease
  • Significant history of hyperglycaemia (HbA1c \>85 mmol/mol)
  • History of severe hypoglycaemia requiring third party assistance within the last 3 months
  • Body weight \<36.5kg
  • Difficulty swallowing tablets
  • Appointment for an MRI test that cannot be rescheduled
  • Obstructive gastrointestinal disease
  • History of gastrointestinal surgery
  • Have an implanted medical device

Study details
    Type 1 Diabetes (T1D)

NCT07341243

Liverpool John Moores University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.